The Endovascular Treatment Devices Market Size is valued at 3486.16 Million in 2024 and is predicted to reach 8398.23 Million by the year 2034 at a 9.4% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
Endovascular surgery is a cutting-edge, minimally invasive operation used to treat medical disorders affecting the blood vessels, such as an aneurysm, a bulging or "ballooning" of the blood vessel. The procedure begins with a bodily incision to allow access to the blood vessels. A flexible, plastic tube, stents, or catheter is put into the damaged blood vessel to allow medication withdrawal or delivery from the patient's bloodstream. Endovascular treatment devices are utilized in various therapies, including intravenous antibiotic treatment, long-term intravenous nutrition, chemotherapy, and blood transfusions.
The endovascular treatment devices market is expected to grow during the forecast period, owing to factors such as an increasing geriatric population base, an increase in the prevalence of cardiovascular diseases, technologically advanced endovascular products, and increased expenditure on research and development by market participants. However, the high expense of endovascular operations, a lack of awareness in economically underdeveloped nations, and a shortage of competent surgeons to execute the surgeries stifle market growth.
Due to the medical field's focus on treating COVID-19, funding for R&D efforts connected to endovascular therapy has been curtailed, and this segment has been neglected, resulting in a negative impact on the endovascular treatment devices market. Rising healthcare spending is accelerating research and development, and breakthrough product launches in endovascular treatment devices have increased the usage of these devices.
The Endovascular Treatment Devices market is segmented on the product, procedure, and indication. Based on product, the market is segmented into percutaneous endovascular aneurysm repair (EVAR), fenestrated EVAR, aortic stents biodegradable stents, self-expanding nitinol stents, thoracic aortic aneurysm grafts and other devices. Based on procedure, the Endovascular Treatment Devices are segmented into balloon angioplasty, stent replacement, drug-eluting stents, renal artery angioplasty and stenting carotid artery, thrombosis, renal artery angioplasty and stenting, transfemoral carotid artery revascularization and intravascular brachytherapy and carotid artery stenting. Based on the application, the Endovascular Treatment Devices are segmented into pulmonary, vascular, cardiology surgery, neurology and radiology.
Based on product, the market is segmented into percutaneous endovascular aneurysm repair (EVAR), fenestrated EVAR, aortic stents biodegradable stents, self-expanding nitinol stents, thoracic aortic aneurysm grafts and other devices. The percutaneous endovascular aneurysm repair (EVAR) segment dominated the market. Endovascular Aneurysm Repair (EVAR), a popular, safe, and effective procedure, is frequently used to repair abdominal aortic aneurysms. The surgical cutdown that is commonly employed to treat this problem over the common femoral arteries has been replaced by percutaneous access methods in several recent studies. By learning more about different percutaneous procedures, including dangers, issues, adjuncts, and alternative approaches, one can improve the results and accessibility of EVAR.
Based on the application, the Endovascular Treatment Devices are segmented into pulmonary, vascular, cardiology surgery, neurology and radiology. The cardiology segment dominated the market. The prevalence of cardiovascular disorders is rising worldwide, which helps this market grow. Cardiovascular diseases (CVDs) are the major reason for death worldwide. Endovascular therapy, which treats cardiovascular disease from within the blood artery, changes how heart attacks, strokes, and other cardiovascular disorders are treated. Many cardiac and vascular conditions that once needed invasive surgery can now be treated internally. These are the main elements influencing the segment's expansion.
The North American Endovascular Treatment Devices market is expected to register the highest market share in revenue in the near future. The expansion of the market is attributable to an increase in surgical procedures and a rise in the preference for these devices among medical professionals, which has prompted large companies to concentrate on the creation of cutting-edge medical devices in these nations. The obesity and diet epidemics in the area, together with the introduction of new products as a result of the presence of top manufacturers there, will all contribute to the region's Endovascular Therapy Devices market expansion. The endovascular treatment device market is anticipated to develop in response to a favourable reimbursement environment for endovascular operations. In addition, Asia Pacific is projected to grow rapidly in the global Endovascular Treatment Devices market. Increased medical advancements have contributed to the endovascular treatment devices market revenue growth in this area, leading to continuing industry expansion. Increased R&D efforts and medical improvements made by significant participants in the region's nations can also be credited with growth.
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 3486.16 Million |
| Revenue Forecast In 2034 | USD 8398.23 Million |
| Growth Rate CAGR | CAGR of 9.4% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Million, volume (units) and CAGR from 2024 to 2031 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Product, Procedure, Application |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; Japan; India; South Korea; South East Asia |
| Competitive Landscape | Cardinal Health , Endospan, Geting AB, Bosten Scientific Corporation, Inspire MD, Japan Lifeline Co., Ltd., Medtronic, Lombord Medical, Penumbra, Inc., Terumo Corporation |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
By Product-
By Procedure-
By Application-
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.